Literature DB >> 32413579

Ultrasmall gold nanoparticles (2 nm) can penetrate and enter cell nuclei in an in vitro 3D brain spheroid model.

Viktoriya Sokolova1, Goodwell Nzou2, Selina B van der Meer1, Tatjana Ruks1, Marc Heggen3, Kateryna Loza1, Nina Hagemann4, Florian Murke5, Bernd Giebel5, Dirk M Hermann4, Anthony J Atala2, Matthias Epple6.   

Abstract

The neurovascular unit (NVU) is a complex functional and anatomical structure composed of endothelial cells and their blood-brain barrier (BBB) forming tight junctions. It represents an efficient barrier for molecules and drugs. However, it also prevents a targeted transport for the treatment of cerebral diseases. The uptake of ultrasmall nanoparticles as potential drug delivery agents was studied in a three-dimensional co-culture cell model (3D spheroid) composed of primary human cells (astrocytes, pericytes, endothelial cells). Multicellular 3D spheroids show reproducible NVU features and functions. The spheroid core is composed mainly of astrocytes, covered with pericytes, while brain endothelial cells form the surface layer, establishing the NVU that regulates the transport of molecules. After 120 h cultivation, the cells self-assemble into a 350 µm spheroid as shown by confocal laser scanning microscopy. The passage of different types of fluorescent ultrasmall gold nanoparticles (core diameter 2 nm) both into the spheroid and into three constituting cell types was studied by confocal laser scanning microscopy. Three kinds of covalently fluorophore-conjugated gold nanoparticles were used: One with fluorescein (FAM), one with Cy3, and one with the peptide CGGpTPAAK-5,6-FAM-NH2. In 2D cell co-culture experiments, it was found that all three kinds of nanoparticles readily entered all three cell types. FAM- and Cy3-labelled nanoparticles were able to enter the cell nucleus as well. The three dissolved dyes alone were not taken up by any cell type. A similar situation evolved with 3D spheroids: The three kinds of nanoparticles entered the spheroid, but the dissolved dyes did not. The presence of a functional blood-brain barrier was demonstrated by adding histamine to the spheroids. In that case, the blood-brain barrier opened, and dissolved dyes like a FITC-labelled antibody and FITC alone entered the spheroid. In summary, our results qualify ultrasmall gold nanoparticles as suitable carriers for imaging or drug delivery into brain cells (sometimes including the nucleus), brain cell spheroids, and probably also into the brain. STATEMENT OF SIGNIFICANCE: 3D brain spheroid model and its permeability by ultrasmall gold nanoparticles. We demonstrate that ultrasmall gold nanoparticles can easily penetrate the constituting cells and sometimes even enter the cell nucleus. They can also enter the interior of the blood-brain barrier model. In contrast, small molecules like fluorescing dyes are not able to do that. Thus, ultrasmall gold nanoparticles can serve as carriers of drugs or for imaging inside the brain.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Blood brain barrier; Cytotoxicity; Gold; Nanoparticles; Neurovascular unit; Spheroids

Mesh:

Substances:

Year:  2020        PMID: 32413579     DOI: 10.1016/j.actbio.2020.04.023

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  10 in total

Review 1.  Progress, Opportunities, and Challenges of Magneto-Plasmonic Nanoparticles under Remote Magnetic and Light Stimulation for Brain-Tissue and Cellular Regeneration.

Authors:  Muzhaozi Yuan; Mackenzie Caitlin Harnett; Tian-Hao Yan; Elias Georgas; Yi-Xian Qin; Hong-Cai Zhou; Ya Wang
Journal:  Nanomaterials (Basel)       Date:  2022-06-29       Impact factor: 5.719

2.  pH-responsive hybrid platelet membrane-coated nanobomb with deep tumor penetration ability and enhanced cancer thermal/chemodynamic therapy.

Authors:  Huang Yang; Yuan Ding; Zongrui Tong; Xiaohui Qian; Hao Xu; Fenghao Lin; Guoping Sheng; Liangjie Hong; Weilin Wang; Zhengwei Mao
Journal:  Theranostics       Date:  2022-05-16       Impact factor: 11.600

3.  Targeting the Surface of the Protein 14-3-3 by Ultrasmall (1.5 nm) Gold Nanoparticles Carrying the Specific Peptide CRaf.

Authors:  Tatjana Ruks; Kateryna Loza; Marc Heggen; Christian Ottmann; Peter Bayer; Christine Beuck; Matthias Epple
Journal:  Chembiochem       Date:  2021-01-28       Impact factor: 3.164

Review 4.  Construction and imaging of a neurovascular unit model.

Authors:  Taiwei Dong; Min Li; Feng Gao; Peifeng Wei; Jian Wang
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

Review 5.  Gold Nanoparticles Contact with Cancer Cell: A Brief Update.

Authors:  Nora Bloise; Silvia Strada; Giacomo Dacarro; Livia Visai
Journal:  Int J Mol Sci       Date:  2022-07-12       Impact factor: 6.208

Review 6.  Organoids and microphysiological systems: Promising models for accelerating AAV gene therapy studies.

Authors:  Ritu Mahesh Ramamurthy; Anthony Atala; Christopher D Porada; Graҫa Almeida-Porada
Journal:  Front Immunol       Date:  2022-09-26       Impact factor: 8.786

Review 7.  Biomolecular interactions of ultrasmall metallic nanoparticles and nanoclusters.

Authors:  Alioscka A Sousa; Peter Schuck; Sergio A Hassan
Journal:  Nanoscale Adv       Date:  2021-04-28

8.  Synergic fabrication of pembrolizumab loaded doxorubicin incorporating microbubbles delivery for ultrasound contrast agents mediated anti-proliferation and apoptosis.

Authors:  Huilin Liu; Xing Li; Zihe Chen; Lianjie Bai; Ying Wang; Weiyang Lv
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

9.  Transport of ultrasmall gold nanoparticles (2 nm) across the blood-brain barrier in a six-cell brain spheroid model.

Authors:  Viktoriya Sokolova; Gehad Mekky; Selina Beatrice van der Meer; Michael C Seeds; Anthony J Atala; Matthias Epple
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

10.  Covalent Attachment of Aggregation-Induced Emission Molecules to the Surface of Ultrasmall Gold Nanoparticles to Enhance Cell Penetration.

Authors:  Kai Klein; Matthias Hayduk; Sebastian Kollenda; Marco Schmiedtchen; Jens Voskuhl; Matthias Epple
Journal:  Molecules       Date:  2022-03-09       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.